PARTNER MOVES - DLA Piper welcomes Lily Wound as a partner in the corporate practice
DLA Piper is pleased to welcome New York-based Lily Wound as a partner in the firm’s Corporate practice.
Wound represents pharmaceutical, biotechnology, and other life sciences companies in a wide range of complex commercial, corporate, and licensing transactions, including those involving gene therapy, gene editing, engineered cell therapy, and genomic testing. She has worked on some of the most complex life sciences collaborations in the industry and has handled transactions at every stage of the product life cycle.